Sanofi Ventures
8 rounds tracked since 9 February 2026.
- Rounds
- 8
- Led
- 2
- Capital in these rounds
- $1B
Sectors
Countries
Rounds
- Matchpoint TherapeuticsDevelops oral covalent medicines for autoimmune and inflammatory diseases $150MSeries B · 7 Oct
- Epicrispr BiotechnologiesDevelops epigenetic gene therapies that control gene expression to treat complex diseases like FSHD. $90MSeries C · 11 Aug
- QuantHealthAI platform simulating clinical trials for biopharmaceutical drug development $45MSeries B · 4 Aug
- AdvanCellDevelops targeted alpha therapies for cancer and expands clinical and commercial manufacturing capacity. $315MSeries D · 15 Jul
- Bionyra PharmaDevelops next-generation biologics for immune-mediated inflammatory diseases, including atopic dermatitis and inflammatory bowel disease. $165MSeries A · 22 Jun
- Nura BioDevelops neuroprotective small molecule therapies for neurological diseases, targeting axon degeneration. $73.8MSeries B · 22 Jun
- QuantXLeadDevelops oral small-molecule medicines using computationally driven drug discovery platform for immune and inflammatory diseases. $85MSeries B · 10 Feb
- QuantX BiosciencesLeadDevelops life sciences technologies, based on the headline only. $85MSeries B · 9 Feb
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise